INSP
Price
$141.90
Change
-$7.51 (-5.03%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
6.35B
32 days until earnings call
MASI
Price
$144.28
Change
-$8.09 (-5.31%)
Updated
Apr 4, 02:43 PM (EDT)
Capitalization
7.66B
39 days until earnings call
Ad is loading...

INSP vs MASI

Header iconINSP vs MASI Comparison
Open Charts INSP vs MASIBanner chart's image
Inspire Medical Systems
Price$141.90
Change-$7.51 (-5.03%)
Volume$3.07K
Capitalization6.35B
Masimo
Price$144.28
Change-$8.09 (-5.31%)
Volume$520
Capitalization7.66B
INSP vs MASI Comparison Chart
Loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSP vs. MASI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a Hold and MASI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (INSP: $149.41 vs. MASI: $152.37)
Brand notoriety: INSP and MASI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INSP: 100% vs. MASI: 177%
Market capitalization -- INSP: $6.35B vs. MASI: $7.66B
INSP [@Medical Specialties] is valued at $6.35B. MASI’s [@Medical Specialties] market capitalization is $7.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSP’s FA Score shows that 0 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • INSP’s FA Score: 0 green, 5 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, MASI is a better buy in the long-term than INSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSP’s TA Score shows that 4 TA indicator(s) are bullish while MASI’s TA Score has 3 bullish TA indicator(s).

  • INSP’s TA Score: 4 bullish, 6 bearish.
  • MASI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, INSP is a better buy in the short-term than MASI.

Price Growth

INSP (@Medical Specialties) experienced а -7.16% price change this week, while MASI (@Medical Specialties) price change was -9.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.66%. For the same industry, the average monthly price growth was -2.14%, and the average quarterly price growth was -1.28%.

Reported Earning Dates

INSP is expected to report earnings on May 06, 2025.

MASI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-5.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.66B) has a higher market cap than INSP($6.35B). MASI YTD gains are higher at: -7.822 vs. INSP (-19.403). MASI has higher annual earnings (EBITDA): 237M vs. INSP (-17.06M). INSP has more cash in the bank: 460M vs. MASI (163M). INSP has less debt than MASI: INSP (24.8M) vs MASI (970M). MASI has higher revenues than INSP: MASI (2.05B) vs INSP (625M).
INSPMASIINSP / MASI
Capitalization6.35B7.66B83%
EBITDA-17.06M237M-7%
Gain YTD-19.403-7.822248%
P/E RatioN/A95.93-
Revenue625M2.05B31%
Total Cash460M163M282%
Total Debt24.8M970M3%
FUNDAMENTALS RATINGS
INSP vs MASI: Fundamental Ratings
INSP
MASI
OUTLOOK RATING
1..100
614
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
7595
PRICE GROWTH RATING
1..100
8249
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INSP's Valuation (81) in the Medical Specialties industry is in the same range as MASI (90). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

INSP's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for MASI (100). This means that INSP’s stock grew somewhat faster than MASI’s over the last 12 months.

INSP's SMR Rating (75) in the Medical Specialties industry is in the same range as MASI (95). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

MASI's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for INSP (82). This means that MASI’s stock grew somewhat faster than INSP’s over the last 12 months.

MASI's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for INSP (100). This means that MASI’s stock grew significantly faster than INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSPMASI
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 8 days ago
72%
Bearish Trend 15 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FIXD44.200.29
+0.66%
First Trust TCWOpportunistic Fxd Inc ETF
IBMR25.140.13
+0.52%
iShares iBonds Dec 2029 Term Muni Bd ETF
INDY50.28-0.48
-0.95%
iShares India 50 ETF
FIG20.94-0.60
-2.77%
Simplify Macro Strategy ETF
DXJS32.98-1.57
-4.54%
WisdomTree Japan Hedged SmallCap Eq ETF

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with INSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
-11.14%
INSP - MASI
47%
Loosely correlated
-6.36%
TMCI - MASI
38%
Loosely correlated
-5.89%
ISRG - MASI
36%
Loosely correlated
-2.45%
HBIO - MASI
35%
Loosely correlated
-19.52%
VCYT - MASI
35%
Loosely correlated
-5.51%
More